FGF21 and metabolic dysfunction-associated steatotic liver disease: In livers from mouse models for NAFLD and of those from the same mice treated with FGF21 (mimicking fasting conditions and improved liver metabolism) two miRNA nodes, sharing the same targets, were identified to coordinate the regulation of hepatic energy metabolism and insulin sensitivity.